Indegene
Health Information Services · INDGN
Mid CapHealthcareHigh Growth
Manish Gupta
Chairman, Executive Director and CEO · Visionary
Company DNA
Innovation-Led
About
Indegene is a Mid Cap company in the Healthcare sector, listed on NSE as INDGN. With a market cap of ₹11K Cr and revenue of ₹3K Cr, it is currently in the High Growth phase. Known for its Innovation-Led culture and Disruptor approach to innovation, the company operates at a Startup-Speed pace. High promoter holding with a strong focus on the Chairman's vision and centralized control over operational growth. Its strategic mandate: Capitalizing on the agricultural value chain requires deep downstream integration and stronger customer relationships.
FAQ
What kind of company is Indegene?
Indegene is a Mid Cap Healthcare company (INDGN) in the High Growth phase with a market cap of ₹11K Cr. It is classified as Innovation-Led in culture.
What is Indegene's culture and work environment like?
Indegene has a Innovation-Led culture with Disruptor innovation DNA and a Startup-Speed pace of execution. Employee brand: Learning Ground. Customer relationship style: B2B-Enterprise. High promoter holding with a strong focus on the Chairman's vision and centralized control over operational growth.
Who leads Indegene?
Indegene is led by Manish Gupta (Chairman, Executive Director and CEO), a Visionary leader with 27 years of experience.
What are Indegene's financials?
Indegene reported revenue of ₹3K Cr in FY25 with a 5-year revenue CAGR of 19.5%. Operating margin: 16%. Market cap: ₹11K Cr.
Culture & Strategy
CultureInnovation-Led
InnovationDisruptor
PaceStartup-Speed
PurposePurpose-Blended
CustomerB2B-Enterprise
EmployeeLearning Ground
BrandTechnical-Expert
LifecycleHigh Growth
High promoter holding with a strong focus on the Chairman's vision and centralized control over operational growth.
Mandate
Capitalizing on the agricultural value chain requires deep downstream integration and stronger customer relationships.
Capitalizing on the agricultural value chain requires deep downstream integration and stronger customer relationships.
Financials
Revenue FY25₹3K Cr
PAT FY25₹407 Cr
Rev CAGR 5Y19.5%
OPM16%
NPM14.3%
ROE15.5%
ROCE16.4%
P/E23.6
Fwd P/E20
P/B1.9
D/E4.3
Mkt Cap₹11K Cr
Promoter57.1%
Institutional22.3%
Similar Culture
Could You Lead Indegene?
Take the Genome Benchmark →